Acumen Pharmaceuticals Statistics
NASDAQ: ABOSHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
2.10+0.07 (+3.45%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Acumen Pharmaceuticals by the numbers
Acumen Pharmaceuticals has a market capitalization of $151.9 million based on 72.32M shares outstanding. With trailing EPS of $-1.64, Acumen Pharmaceuticals is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 19.4% below its 50-day average and 16.3% below its 200-day average.
Average daily trading volume is 432.46K shares, or about $908,172 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
ABOS valuation vs. peer median
| Metric | ABOS | Peer median | Difference |
|---|---|---|---|
| Market cap | $151.87M | $149.07M | +2% |
| Avg. volume | 432.46K | 883.21K | -51% |
Peer median across 8 companies: VYGR, TARA, CHRS, MOLN, OTLK, CRDL, AVXL, ARMP.
Valuation
- Market cap
- $151.87M
- EPS (TTM)
- $-1.64
- Shares outstanding
- 72.32M
Price and trading
- Previous close
- 2.03
- Open
- 2.02
- Day range
- 2.01 – 2.17
- 52-week range
- 1.50 – 3.60
- 52-week change
- +11.70%
- Beta
- —
- Volume
- 622.92K
- Average volume
- 432.46K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Aug 12, 2026
Additional statistics
- Market Cap
- 151.87M
- Forward Pe
- -1.47
- Eps
- -1.64
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 3.60
- Week52 Low
- 1.50
- Avg Volume
- 432.46K
- Shares Outstanding
- 72.32M
- Ma50
- 2.60
- Ma200
- 2.51
- Earnings Date
- Aug 12, 2026
- Pct From52w High
- -41.67%
- Pct From52w Low
- 40.00%